Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Maiwei Biological-B (02493) priced its share at HKD 27.64 per share. Public offering was oversubscribed 481.71 times.
HK ENT INTL (08291) recommends adopting the 2026 stock option plan.
On April 27th, JACOBIO-B (01167) spent 472,800 Hong Kong dollars to repurchase 66,000 shares.
Maiwei Biological-B (02493) priced its share at HKD 27.64 per share. Public offering was oversubscribed 481.71 times.
HK ENT INTL (08291) recommends adopting the 2026 stock option plan.
On April 27th, JACOBIO-B (01167) spent 472,800 Hong Kong dollars to repurchase 66,000 shares.
